Pages that link to "Q38484316"
Jump to navigation
Jump to search
The following pages link to Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial (Q38484316):
Displaying 35 items.
- Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions (Q27021524) (← links)
- The end of AIDS: HIV infection as a chronic disease (Q28300749) (← links)
- Clinical use of HIV integrase inhibitors: a systematic review and meta-analysis (Q28484930) (← links)
- Controlling the HIV/AIDS epidemic: current status and global challenges (Q30420558) (← links)
- Systemic effects of inflammation on health during chronic HIV infection (Q33577551) (← links)
- Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial (Q33934080) (← links)
- Residual immune dysregulation syndrome in treated HIV infection (Q34020121) (← links)
- Mucosal immunity in human and simian immunodeficiency lentivirus infections (Q34131265) (← links)
- Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals (Q34612385) (← links)
- Persistent immune activation in chronic HIV infection: do any interventions work? (Q34851102) (← links)
- Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities (Q35204909) (← links)
- Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation (Q35273346) (← links)
- Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy. (Q35630665) (← links)
- Microbial translocation and microbiome dysbiosis in HIV-associated immune activation (Q35872112) (← links)
- Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors (Q36063953) (← links)
- Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes (Q37244544) (← links)
- Short communication: Evidence that microbial translocation occurs in HIV-infected children in the United Kingdom (Q37359248) (← links)
- Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy (Q37417396) (← links)
- Serious Non-AIDS events: Immunopathogenesis and interventional strategies (Q37418140) (← links)
- HIV and Inflammation: Mechanisms and Consequences (Q38005046) (← links)
- Microbial translocation in HIV infection: causes, consequences and treatment opportunities (Q38034068) (← links)
- Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy (Q38066127) (← links)
- The search for an HIV cure: tackling latent infection (Q38088556) (← links)
- Immunodiscordant responses to HAART--mechanisms and consequences (Q38156230) (← links)
- Targeting the gastrointestinal tract to develop novel therapies for HIV. (Q38548095) (← links)
- Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection (Q38749963) (← links)
- Persistent HIV-1 replication during antiretroviral therapy (Q38808266) (← links)
- Strategies to limit immune-activation in HIV patients. (Q38985926) (← links)
- Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial. (Q40971975) (← links)
- Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients? (Q42215126) (← links)
- HIV as a Cause of Immune Activation and Immunosenescence (Q47151081) (← links)
- Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence (Q47548203) (← links)
- Epigenetic alterations are associated with monocyte immune dysfunctions in HIV-1 infection. (Q54679094) (← links)
- Is human immunodeficiency virus infection an inflammatory disease? (Q83131103) (← links)
- Colostrum from cows immunized with a veterinary vaccine against bovine rotavirus displays enhanced in vitro anti-human rotavirus activity (Q93074459) (← links)